Caplyta
Articles tagged Caplyta focus on psychiatric prescribing questions, side effects, interactions, alternatives, and practical conversations to have before changing medication.
Caplyta off-label use
Caplyta (lumateperone) is one of the newer atypical antipsychotics, FDA-approved for schizophrenia and bipolar depression, and what's more interesting…
Apr 10, 2026
Caplyta (Lumateperone)
Caplyta is the antipsychotic that came out in 2019 and made a bunch of psychiatrists do a double-take at the receptor pharmacology, then another…
Apr 23, 2025